BM
BME.US BlackRock Health Sciences Trust
- Market cap
- USD 621M
- P/E
- 5.9x
- P/B
- 1.08x
- ROE
- 16.4%
- Dividend yield
- 6.54%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is BME.US undervalued?
Graham numberBME.US trades 46.8% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BlackRock Health Sciences Trust fundamental analysis
No fundamental analysis for BlackRock Health Sciences Trust yet.
BlackRock Health Sciences Trust stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, su…
Full company profileBlackRock Health Sciences Trust financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
BlackRock Health Sciences Trust annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 25.8M | 60.7M | 22.9M | 80.3M | 80.1M | 59.7M | -26.0M | 34.9M | 24.1M | 36.2M | 123M |
| Gross Profit | 22.8M | 60.7M | 22.9M | 80.3M | 80.1M | 59.7M | -26.0M | 28.9M | 24.1M | 30.5M | 112M |
| Operating Income | -16.3M | 60.3M | 22.4M | 79.9M | 79.6M | 59.1M | -26.5M | 8.46M | 23.5M | 77.0M | 94.0M |
| EBITDA | -16.2M | 60.3M | 22.4M | 79.9M | 79.6M | 59.1M | -26.5M | 20.0M | 23.5M | 77.0M | 94.0M |
| Net Income | -16.3M | 60.3M | 22.4M | 79.9M | 79.6M | 59.1M | -26.5M | 20.0M | 23.5M | 77.0M | 93.9M |
| EPS | -1.88 | 6.79 | 2.58 | 0.71 | 0.71 | 0.52 | -2.10 | 1.44 | 1.77 | 5.92 | 7.27 |
| Balance Sheet | |||||||||||
| Total Assets | 274M | 335M | 355M | 1.73B | 555M | 649M | 606M | 596M | 775M | 570M | 575M |
| Total Liabilities | 2.85M | 2.75M | 2.81M | 93.5M | 8.62M | 23.0M | 5.93M | 7.97M | 6.03M | 1.83M | 3.17M |
| Shareholders' Equity | 271M | 332M | 353M | 1.64B | 3.02B | 626M | 600M | 588M | 769M | 568M | 571M |
| Cash & Short-term Investments | 8.95M | 14.4M | 26.0M | 501K | 212K | 960.00 | 3.12K | 534.00 | 26.6M | 4.92M | 19.7M |
| Total Debt | 127K | 131K | 4.68K | 254K | 103K | 212K | 2.92K | 60.7K | 299K | 894K | 688K |
| Cash Flow | |||||||||||
| Operating Cash Flow | 2.01M | -1.17M | 2.05M | -14.1M | -19.4M | -21.6M | -874K | 32.0M | 65.5M | -4.35M | - |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 4.00 | 1.00 | 3.00 | 0.00 | 4.00 | 0.00 |
| Free Cash Flow | 2.01M | -1.17M | 2.05M | -14.1M | -19.4M | -21.6M | -874K | 32.0M | 65.5M | -4.35M | - |
| Ratios | |||||||||||
| ROE | -6.0% | 18.2% | 6.4% | 4.9% | 2.6% | 9.4% | -4.4% | 3.4% | 3.1% | 13.5% | 16.4% |
| ROA | -5.9% | 18.0% | 6.3% | 4.6% | 14.3% | 9.1% | -4.4% | 3.4% | 3.0% | 13.5% | 16.3% |
| Net Profit Margin | -63.0% | 99.4% | 98.0% | 99.5% | 99.3% | 99.1% | - | 57.4% | 97.4% | 212.9% | 76.4% |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
BlackRock Health Sciences Trust dividends
- Dividend yield
- 6.54%
- Forward dividend
- 3.15 USD
- Payout ratio
- 52.8%
- Ex-dividend date
- Dec 11, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 40.6M | 3.12 | 52.8% |
| 2024 | USD 35.9M | 2.71 | 153.2% |
| 2023 | USD 35.1M | 2.52 | 175.3% |
| 2022 | USD 32.7M | 2.60 | - |
| 2021 | USD 29.0M | 0.26 | 49.1% |
| 2020 | USD 25.6M | 0.23 | 32.2% |
| 2019 | USD 23.2M | 0.21 | 29.1% |
| 2018 | USD 21.6M | 2.48 | 96.3% |
| 2017 | USD 20.0M | 2.25 | 33.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns BlackRock Health Sciences Trust
- Insiders 0.02%
- Institutions 20.01%
- Public & others 79.97%
- Shares outstanding 12.9M
BlackRock Health Sciences Trust company profile
- Company name
- BlackRock Health Sciences Trust
- Ticker
- BME.US
- Exchange
- USA Stocks
- Listed since
- Mar 29, 2005
- Sector
- Financial Services
- Industry
- Capital Markets
- Fiscal year end
- December
- Address
- 50 Hudson Yards, New York, NY, United States, 10001
- Phone
- 212-810-5300
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
BlackRock Health Sciences Trust management
5- Mr. Charles Choon Sik ParkChief Compliance Officer and Anti-Money Laundering Officer · born 1967
- Mr. Thomas P. Callan C.F.A.Portfolio Manager
- Mr. Kyle G. McClements C.F.A.Portfolio Manager
- Dr. Erin Xie Ph.D.Portfolio Manager · born 1968
- Dr. Xiang Liu Ph.D.Portfolio Manager